
Steroidal MRAs Provide Little Benefit, Increase Hyperkalemia Risk in Kidney Transplant Patients
Data from the American College of Physicians Internal Medicine Meeting suggests use of steroidal mineralocorticoid receptor antagonists (MRAs) offered minimal benefit and increased the risk of hyperkalemia among patients with a history of kidney transplant …